Dr. Yao on Transplants Beyond Milan Criteria for Liver Cancer

Video

In Partnership With:

Francis Yao, MD, gastroenterologist and medical director of the Liver Transplant Program at the University of California San Francisco Medical Center, discusses liver transplants beyond Milan criteria for patients with liver cancer.

Francis Yao, MD, gastroenterologist and medical director of the Liver Transplant Program at the University of California San Francisco Medical Center, discusses liver transplants beyond Milan criteria for patients with liver cancer.

Over the past 20 years, physicians' knowledge of liver transplants for patients with liver cancer has increased, explains Yao. In 1996, the Milan criteria was published, suggesting that transplanting in early stages of liver cancer is the best way to achieve positive results. The Milan criteria is one single lesion up to 5 centimeters, or 2 to 3 lesions up to 3 centimeters.

The Milan criteria has been questioned over the past couple of years, according to Yao. There have been some cases where patients have been outside of the Milan criteria and responded positively to the transplant treatment.

Related Videos
Video 10 - "Monitoring and AE Management Strategies with Fruquintinib in CRC"
Video 9 - "FRESCO-2: Fruquintinib in Patients with Refractory Metastatic CRC"
Jeremy M. Pantin, MD, clinical director, Adult Transplant and Cellular Therapy Program, TriStar Centennial Medical Center, bone marrow transplant physician, Sarah Cannon Research Institute
Maria Hafez, MD, assistant professor, breast and sarcoma medical oncologist, director, Clinical Breast Cancer Research, Sidney Kimmel Medical College, Thomas Jefferson University
Zeynep Eroglu, MD
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Akriti Jain, MD
Raj Singh, MD
Gottfried Konecny, MD
Karim Chamie, MD, associate professor, urology, the University of California, Los Angeles